Northrop Grumman stock: 2027 outlook points to 5%-7% sales growth
Published on 10/29/2026 at 17:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSNorthrop Grumman extends its growth outlook
- Management expects growth across all four business segments in 2027.
- Capital spending is planned to support a faster B-21 production rate.
- Strong awards and backlog conversion remain central to the medium-term outlook.
Northrop Grumman added detail to its medium-term growth outlook on October 20, 2026, when the company reported third-quarter results and held its earnings call. In the call, management outlined the drivers behind its 2027 plans, extending the information covered in the company's results release.
The Northrop Grumman earnings release reported third-quarter sales of USD 11.122 billion and diluted earnings per share of USD 7.89. The company also recorded USD 16.4 billion in net awards and backlog of USD 109.6 billion as of September 30.
What changed since the last report
The new element for investors is management's 2027 framework. In the Northrop Grumman earnings-call transcript, Chief Financial Officer John Greene said the company expects sales growth in 2027 across all four segments. He linked the outlook to B-21 production, Sentinel, weapons and munitions, national-security space and international activity.
Management also expects segment operating income to grow faster than sales, with 10 to 20 basis points of margin expansion beyond the midpoint of the current 2026 guidance. Capital expenditure is projected at approximately USD 2.1 billion in 2027, or about 4.5% of sales, as the company builds capacity for a higher B-21 production rate. The transcript also gave a 2027 adjusted free-cash-flow range of USD 3.3 billion to USD 3.7 billion.
Guidance and investor context
For 2026, Northrop Grumman maintained sales guidance of USD 43.75 billion to USD 44.25 billion and adjusted free-cash-flow guidance of USD 3.1 billion to USD 3.5 billion. It raised segment operating-income guidance to USD 4.94 billion to USD 5.04 billion and mark-to-market-adjusted earnings-per-share guidance to USD 29.35 to USD 29.75.
At Lang & Schwarz, Northrop Grumman stock was quoted at EUR 506.80 on October 29, 2026, at 16:09:48 Berlin time. That was 1.93% above the verified Xetra close of EUR 497.20 from October 28, 2026. The quote is available through the real-time quote of Northrop Grumman stock.
Northrop Grumman Corporation
- ISIN: US6668071029
- Ticker: NOC
- Primary exchange: NYSE
- German listing: Deutsche Börse Xetra, NTH
- Lang & Schwarz quote: EUR 506.80 at 16:09:48 Berlin time on October 29, 2026
- Xetra close: EUR 497.20 on October 28, 2026
- Sector: Industrials
- Industry: Aerospace & Defense
Broader market conditions can be followed in the current market reports.
More news and analyses on Northrop Grumman stock are available on the topic page.
